Indirect methods for reference interval determination - Review and recommendations

dc.contributor.authorJones, Graham R. D.
dc.contributor.authorHaeckel, Rainer
dc.contributor.authorLoh, Tze Ping
dc.contributor.authorSikaris, Ken
dc.contributor.authorStreichert, Thomas
dc.contributor.authorKatayev, Alex
dc.contributor.authorBarth, Julian H
dc.contributor.buuauthorÖzarda, Yeşim
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Biyokimya Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0003-0532-789Xtr_TR
dc.contributor.researcheridAAL-8873-2021tr_TR
dc.contributor.scopusid35741320500tr_TR
dc.date.accessioned2022-11-24T13:43:57Z
dc.date.available2022-11-24T13:43:57Z
dc.date.issued2019-01
dc.description.abstractReference intervals are a vital part of the information supplied by clinical laboratories to support interpretation of numerical pathology results such as are produced in clinical chemistry and hematology laboratories. The traditional method for establishing reference intervals, known as the direct approach, is based on collecting samples from members of a preselected reference population, making the measurements and then determining the intervals. An alternative approach is to perform analysis of results generated as part of routine pathology testing and using appropriate statistical techniques to determine reference intervals. This is known as the indirect approach. This paper from a working group of the International Federation of Clinical Chemistry (IFCC) Committee on Reference Intervals and Decision Limits (C-RIDL) aims to summarize current thinking on indirect approaches to reference intervals. The indirect approach has some major potential advantages compared with direct methods. The processes are faster, cheaper and do not involve patient inconvenience, discomfort or the risks associated with generating new patient health information. Indirect methods also use the same preanalytical and analytical techniques used for patient management and can provide very large numbers for assessment. Limitations to the indirect methods include possible effects of diseased subpopulations on the derived interval. The IFCC C-RIDL aims to encourage the use of indirect methods to establish and verify reference intervals, to promote publication of such intervals with clear explanation of the process used and also to support the development of improved statistical techniques for these studies.en_US
dc.identifier.citationJones, G. R. D. (2019). "Indirect methods for reference interval determination - review and recommendations". Clinical Chemistry and Laboratory Medicine, 57(1), Special Issue, 20-29.en_US
dc.identifier.endpage29tr_TR
dc.identifier.issn1434-6621
dc.identifier.issn1437-4331
dc.identifier.issue1, Special Issueen_US
dc.identifier.pubmed29672266tr_TR
dc.identifier.scopus2-s2.0-85046023097tr_TR
dc.identifier.startpage20tr_TR
dc.identifier.urihttps://doi.org/10.1515/cclm-2018-0073
dc.identifier.urihttps://www.degruyter.com/document/doi/10.1515/cclm-2018-0073/html
dc.identifier.urihttp://hdl.handle.net/11452/29560
dc.identifier.volume57tr_TR
dc.identifier.wos000451633000003tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherWalter de Gruyteren_US
dc.relation.collaborationYurt dışıtr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.journalClinical Chemistry and Laboratory Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectDecision limitsen_US
dc.subjectIndirect methodsen_US
dc.subjectPathology testingen_US
dc.subjectReference intervalsen_US
dc.subjectStatistical approachen_US
dc.subjectIndividual biological variationsen_US
dc.subjectDetermining reference limiten_US
dc.subjectReference valuesen_US
dc.subjectHospitalized populationen_US
dc.subjectGlobal multicenteren_US
dc.subjectDerivationen_US
dc.subjectBhattacharyaen_US
dc.subjectProjecten_US
dc.subjectPaperen_US
dc.subjectMedical laboratory technologyen_US
dc.subject.emtreeComparative studyen_US
dc.subject.emtreeCosten_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeMedical informationen_US
dc.subject.emtreeMethodologyen_US
dc.subject.emtreePatient careen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreePublicationen_US
dc.subject.emtreeReference valueen_US
dc.subject.emtreeReviewen_US
dc.subject.emtreeRisk assessmenten_US
dc.subject.emtreeStatistical analysisen_US
dc.subject.emtreeClinical chemistryen_US
dc.subject.emtreeStandarden_US
dc.subject.meshChemistry, clinicalen_US
dc.subject.meshHumansen_US
dc.subject.meshReference standardsen_US
dc.subject.scopusClinical Chemistry; Thyrotropin; Chemical Speciesen_US
dc.subject.wosMedical laboratory technologyen_US
dc.titleIndirect methods for reference interval determination - Review and recommendationsen_US
dc.typeReview
dc.wos.quartileQ1en_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Özarda_vd_2019.pdf
Size:
116.22 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: